Go Pro
NASDAQ:NTRB

Nutriband (NTRB) Stock Price, News & Analysis

Nutriband logo
$2.81 -0.04 (-1.40%)
Closing price 04:00 PM Eastern
Extended Trading
$2.82 +0.02 (+0.53%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Nutriband Stock (NASDAQ:NTRB)

Advanced

Key Stats

Today's Range
$2.81
$2.88
50-Day Range
$2.81
$3.64
52-Week Range
$2.81
$8.63
Volume
5,602 shs
Average Volume
11,083 shs
Market Capitalization
$34.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Nutriband Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
3rd Percentile Overall Score

NTRB MarketRank™: 

Nutriband scored higher than 3% of companies evaluated by MarketBeat, and ranked 882nd out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nutriband has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Nutriband has only been the subject of 1 research reports in the past 90 days.

  • Read more about Nutriband's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nutriband is -1.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nutriband is -1.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nutriband has a P/B Ratio of 5.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Nutriband's valuation and earnings.
  • Percentage of Shares Shorted

    2.70% of the float of Nutriband has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutriband has a short interest ratio ("days to cover") of 11.36, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Nutriband has recently increased by 2.53%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Nutriband does not currently pay a dividend.

  • Dividend Growth

    Nutriband does not have a long track record of dividend growth.

  • MarketBeat Follows

    2 people have added Nutriband to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nutriband insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    52.21% of the stock of Nutriband is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    19.70% of the stock of Nutriband is held by institutions.

  • Read more about Nutriband's insider trading history.
Receive NTRB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NTRB Stock News Headlines

Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
Nutriband Wins Costa Rica OK for Product
See More Headlines

NTRB Stock Analysis - Frequently Asked Questions

Nutriband's stock was trading at $4.54 on January 1st, 2026. Since then, NTRB stock has decreased by 38.1% and is now trading at $2.81.

Nutriband Inc. (NASDAQ:NTRB) announced its earnings results on Thursday, June, 11th. The company reported ($0.10) EPS for the quarter. The company had revenue of $0.43 million for the quarter. Nutriband had a negative trailing twelve-month return on equity of 112.64% and a negative net margin of 448.25%.

Nutriband shares split before market open on Monday, August 15th 2022.The 13-6 split was announced on Monday, August 15th 2022. The newly minted shares were distributed to shareholders after the market closes on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split.

Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nutriband investors own include Jiuzi (JZXN), AMC Entertainment (AMC), Aridis Pharmaceuticals (ARDS), Avenue Therapeutics (ATXI), Esports Entertainment Group (GMBL), Moleculin Biotech (MBRX) and ARMOUR Residential REIT (ARR).

Company Calendar

Last Earnings
6/11/2026
Today
8/03/2026
Next Earnings (Estimated)
9/30/2026
Fiscal Year End
1/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:NTRB
CIK
1676047
Fax
N/A
Employees
10
Year Founded
2016

Profitability

EPS (Trailing Twelve Months)
($2.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.23 million
Net Margins
-448.25%
Pretax Margin
-448.31%
Return on Equity
-112.64%
Return on Assets
-97.86%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.26
Quick Ratio
5.11

Sales & Book Value

Annual Sales
$2.04 million
Price / Sales
16.75
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.55 per share
Price / Book
5.11

Miscellaneous

Outstanding Shares
12,160,000
Free Float
5,809,000
Market Cap
$34.17 million
Optionable
Not Optionable
Beta
1.98

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:NTRB) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners